1 |
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789.
|
|
Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatment of heart failure 2018[J]. Chinese Journal of Cardiology, 2018, 46(10): 760-789.
|
2 |
PONIKOWSKI P, VOORS A A, ANKER S D, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J, 2016, 37(27): 2129-2200.
|
3 |
ZHANG Y, LV X Z, JIANG W, et al. Effectiveness of a telephone-delivered psycho-behavioural intervention on depression in elderly with chronic heart failure: rationale and design of a randomized controlled trial[J]. BMC Psychiatry, 2019, 19(1): 161.
|
4 |
DIMSDALE J E, CREED F, ESCOBAR J, et al. Somatic symptom disorder: an important change in DSM[J]. J Psychosom Res, 2013, 75(3): 223-228.
|
5 |
BATTLE D E. Diagnostic and statistical manual of mental disorders (DSM)[J]. Codas, 2013, 25(2): 191-192.
|
6 |
LIANG D, MAYS V M, HWANG W C. Integrated mental health services in China: challenges and planning for the future[J]. Health Policy Plan, 2018, 33(1): 107-122.
|
7 |
GUIDI J, RAFANELLI C, RONCUZZI R, et al. Assessing psychological factors affecting medical conditions: comparison between different proposals[J]. Gen Hosp Psychiatry, 2013, 35(2): 141-146.
|
8 |
CELANO C M, VILLEGAS A C, ALBANESE A M, et al. Depression and anxiety in heart failure: a review[J]. Harv Rev Psychiatry, 2018, 26(4): 175-184.
|
9 |
HERR J K, SALYER J, FLATTERY M, et al. Heart failure symptom clusters and functional status: a cross-sectional study[J]. J Adv Nurs, 2015, 71(6): 1274-1287.
|
10 |
SALYER J, FLATTERY M, LYON D E. Heart failure symptom clusters and quality of life[J]. Heart Lung, 2019, 48(5): 366-372.
|
11 |
CAO L H, LUO G, CAO L F, et al. Somatization disorder mediates the association of depression and anxiety with functional impairment in patients with heart failure[J]. Psychol Health Med, 2021, 26(7): 911-916.
|
12 |
RUTLEDGE T, REIS V A, LINKE S E, et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes[J]. J Am Coll Cardiol, 2006, 48(8): 1527-1537.
|
13 |
SCHIFFER A A, PELLE A J, SMITH O R, et al. Somatic versus cognitive symptoms of depression as predictors of all-cause mortality and health status in chronic heart failure[J]. J Clin Psychiatry, 2009, 70(12): 1667-1673.
|
14 |
庄琦, 毛家亮, 李春波, 等. 躯体化症状自评量表的初步编制及信度和效度研究[J]. 中华行为医学与脑科学杂志, 2010, 19(9): 847-849.
|
|
ZHUANG Q, MAO J L, LI C B, et al. Developing of Somatic Self-rating Scale and its reliability and validity[J]. Chinese Journal of Behavioral Medical and Brain Science, 2010, 19(9): 847-849.
|
15 |
KROENKE K, SPITZER R L, WILLIAMS J B. The PHQ-9: validity of a brief depression severity measure[J]. J Gen Intern Med, 2001, 16(9): 606-613.
|
16 |
SPITZER R L, KROENKE K, WILLIAMS J B W, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7[J]. Arch Intern Med, 2006, 166(10): 1092-1097.
|
17 |
中华医学会神经病学分会神经心理学与行为神经病学组. 综合医院焦虑、抑郁与躯体化症状诊断治疗的专家共识[J]. 中华神经科杂志, 2016, 49(12): 908-917.
|
|
Neuropsychology and Behavioral Neurology Group of Chinese Society of Neurology of Chinese Medical Association. Expert consensus on the diagnosis and treatment of anxiety, depression and somatic symptoms in general hospitals[J]. Chinese Journal of Neurology, 2016, 49(12): 908-917.
|
18 |
HEIDENREICH P A, BOZKURT B, AGUILAR D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(18): e876-e894.
|
19 |
PARKER G, BROTCHIE H. Gender differences in depression[J]. Int Rev Psychiatry, 2010, 22(5): 429-436.
|
20 |
SCIOMER S, MOSCUCCI F, SALVIONI E, et al. Role of gender, age and BMI in prognosis of heart failure[J]. Eur J Prev Cardiol, 2020, 27(2_suppl): 46-51.
|
21 |
FERRARI R. Ivabradine: heart rate and left ventricular function[J]. Cardiology, 2014, 128(2): 226-230.
|
22 |
SWEDBERG K, KOMAJDA M, BÖHM M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study[J]. Lancet, 2010, 376(9744): 875-885.
|
23 |
LEE C S, GELOW J M, DENFELD Q E, et al. Physical and psychological symptom profiling and event-free survival in adults with moderate to advanced heart failure[J]. J Cardiovasc Nurs, 2014, 29(4): 315-323.
|
24 |
PATEL H, SHAFAZAND M, SCHAUFELBERGER M, et al. Reasons for seeking acute care in chronic heart failure[J]. Eur J Heart Fail, 2007, 9(6/7): 702-708.
|
25 |
DASKALOPOULOU M, GEORGE J, WALTERS K, et al. Depression as a risk factor for the initial presentation of twelve cardiac, cerebrovascular, and peripheral arterial diseases: data linkage study of 1.9 million women and men[J]. PLoS One, 2016, 11(4): e0153838.
|
26 |
FRIEDMANN E, THOMAS S A, LIU F, et al. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality[J]. Am Heart J, 2006, 152(5): 940.e1-940.e8.
|
27 |
CELANO C M, MILLSTEIN R A, BEDOYA C A, et al. Association between anxiety and mortality in patients with coronary artery disease: a meta-analysis[J]. Am Heart J, 2015, 170(6): 1105-1115.
|
28 |
CELANO C M, MASTROMAURO C A, LENIHAN E C, et al. Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness[J]. Psychosom Med, 2012, 74(1): 93-99.
|